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CEREBROVASCULAR RISK FACTORS - IN VIEW
OF STROKE PREVENTION
Angela K. Schreiber and Roman L. Haberl
University Department of Neurology, Städtisches Krankenhaus München-Harlaching, Germany
SUMMARY · Stroke risk factors can be divided into those with evidence-based relationship and
those with supposed relationship to ischemic stroke, and into potentially treatable risk factors and
risk factors with no therapeutic options. Age, gender and race are risk factors with no therapeutic
options, while among treatable stroke risk factors most important are high blood pressure, atrial fi-
brillation, patent foramen ovale, cardiac disorders, diabetes mellitus, hiperhomocysteinemia,
hiperlipidemia, and living conditions such as smoking and heavy alcohol drinking. Data about the
use of antioxidant vitamins (A,C,E,) are still controversial as well as the role of infection in the de-
velopment of atherosclerosis.
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Talking about crebrovascular risk factors, we have to
divide them into risk factors with evidence-based relation-
ship and those with supposed relationship to ischemic
stroke. For stroke prevention, differentiation between the
potentially treatable risk factors and risk factors with no
therapeutic options is especially important.
No Therapeutic Options
Among risk factors with no therapeutic options, age
certainly is the most important independent risk factor.
Furthermore, male gender, positive family history, and
black or Asian race are associated with an increased stroke
risk. There is a positive correlation between stroke mor-
tality and low temperatures as well as with the prevalence
of respiratory tract infections. Although these risk factors
can hardly be modified, their identification should lead to
a screening for other risk factors that can be modified by
vigorous treatment.
Potentially Therapeutic Options
Besides age, high blood pressure certainly is the most
important risk factor for stroke, where appropriate an-
tihypertensive therapy quickly leads to a relative risk re-
duction by up to 40%. This benefit has been demon-
strated for all age groups as well as for slightly elevated
blood pressure and isolated systolic hypertension. Fur-
thermore, treatment with ACE inhibitors such as
ramipril could show some protective effect on vascular
walls (HOPE study), in addition to their antihyperten-
sive effect1-3.
One third of all ischemic strokes are due to cardiac
embolism with atrial fibrillation being the most impor-
tant underlying cause. There is a positive correlation be-
tween atrial fibrillation and age as well as a further increase
in stroke risk if there is a history of diabetes, hyperten-
sion or congestive heart failure. Treatment with moder-
ate oral anticoagulation (INR 2.0-3.0) lowers the yearly
stroke risk by up to 5% with an intracranial bleeding rate
of 0.5% and total bleeding rate of nearly 2%. Warfarin has
been shown to be more effective than aspirin in the pre-
vention of stroke due to atrial fibrillation, however, the
patient’s age and an additional risk profile should be con-
sidered in the choice of treatment1,2,4,5.
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A patent foramen ovale (PFO) can cause stroke via
paradoxical embolism. The risk of embolization increases
with PFO size and prevalence of hypermobile atrial sep-
tum or atrial septum aneurysm. Besides platelet inhibitors
and oral anticoagulants, surgical and transcatheter closure
have been discussed in view of stroke prevention and should
be further investigated in case - control studies6.
Other cardiac disorders such as sick sinus syndrome,
dilatative cardiomyopathy, and those with impaired left
ventricular function, e.g., large myocardial infarctions, also
are associated with an increased risk of embolic stroke.
Oral anticoagulation in view of stroke prevention should
therefore be critically considered1,2.
Insulin resistance, hyperglycemia, and manifested dia-
betes mellitus all are independent risk factors for stroke
as well, with small and large vessel arteriosclerosis being
the consequence of poor metabolic control. Therefore,
HbA1c levels below 7% should be achieved according to
the UKPD Study, which demonstrated positive relation-
ship between the reduction of stroke risk and well con-
trolled diabetes mellitus1,2,7.
Hyperhomocysteinemia has recently also been dem-
onstrated to be associated with arteriosclerosis of large,
and especially of small cerebral vessels, thus leading to an
increased stroke risk. A daily intake of 5 mg folic acid can
lower the blood levels of homocysteine, however, data are
still lacking which would show that this can also reduce
the stroke risk8,9.
The important role of hyperlipidemia as a risk factor
for cerebral ischemia has been confirmed many times.
Three large studies demonstrated that even in patients
with normal cholesterol levels, the intake of statins (shown
for simvastatin and pravastatin) reduced the absolute risk
of stroke. An LDL-cholesterol level below 100 mg/dl
should be achieved1,2,10-12.
A history of transient ischemic attack (TIA) increases
the stroke risk by up to 20% in the first 6 to 12 months.
So, each TIA should be followed by search for the under-
lying cause. TIAs due to carotid stenosis are especially re-
lated to an increased stroke risk. Furthermore, asymptom-
atic carotid artery stenosis also is associated with an in-
creased stroke risk of approximately 1.3% (stenosis <75%)
to 3.3% (stenosis >75%) per year. Opinions on conserva-
tive management with platelet inhibitors versus surgical
intervention, e.g., stenting or carotid endarterectomy, are
still controversial.
Living conditions are also related to the incidence of
stroke. Smoking leads to a dose-dependent increase in
stroke risk, whereas smoking cessation is associated with
a rapid decrease in this risk. The role of alcohol consump-
tion is still a matter of controversy and discussion. Heavy
alcohol drinking has been clearly demonstrated as a risk
factor for intracerebral hemorrhage, while the potentially
protective effect of moderate alcohol use awaits to be defi-
nitely determined. Data concerning the substitution of
antioxidant vitamins (A, C and especially E) are still con-
tradictory, therefore daily vitamin supplementation for
stroke prevention cannot yet be recommended1,2,13.
Finally, the importance of bacterial and viral infections
remains unclear as yet. The role of infective triggers in the
development of arteriosclerosis (e.g., Chlamydia pneumo-
niae and others) within the concept of ‘pathogenic bur-
den’ has yet to be elucidated14.
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SAÆETAK
RIZI»NI »IMBENICI ZA NASTANAK CEREBROVASKULARNIH BOLESTI
S OSVRTOM NA PREVENCIJU
A. K. Schreiber i R. L. Haberl
RiziËni Ëimbenici za nastanak moædanog udara mogu se podijeliti na one kod kojih je povezanost s moædanim udarom
dokazana i na one kod kojih se ta povezanost pretpostavlja, na one na koje se moæe terapijski djelovati i one na koje se ne
moæe djelovati. RiziËni Ëimbenici na koje se ne moæe djelovati su dob, spol, rasa, dok su meðu onima na koje se moæe djelovati
najvaæniji povi¹en tlak, atrijska fibrilacija, otvoreni foramen ovale, srËani poremeÊaji, ¹eÊerna bolest, hiperhomocisteinemija,
hiperlipidemija, te Ëimbenici povezani s naËinom æivota, kao ¹to su pu¹enje i prekomjerno pijenje alkohola. Podaci o primjeni
antiokdisativnih vitamina (A, C i E) jo¹ uvijek nisu nedvosmisleni, ¹to takoðer vrijedi i za ulogu upale u nastanku ateroskleroze.
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